<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Professor MA Rou has been engaged in clinical and basic research of hematology for more than 40 years </plain></SENT>
<SENT sid="1" pm="."><plain>He is excel in the treatment of refractory <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> under the guidance of holism and syndrome differentiation in Chinese medicine </plain></SENT>
<SENT sid="2" pm="."><plain>Application of <z:chebi fb="107" ids="27563">arsenic</z:chebi>-containing Chinese herbal medicine in treating <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), primary <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>), <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">primary thrombocythemia</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e>-ET), <z:e sem="disease" ids="C0854809" disease_type="Neoplastic Process" abbrv="">MDS-U</z:e>, <z:mpath ids='MPATH_512'>myeloproliferative disease</z:mpath>, <z:hpo ids='HP_0011009'>acute</z:hpo> non lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> except for promyelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, Prof </plain></SENT>
<SENT sid="3" pm="."><plain>MA has made great innovation and exploration </plain></SENT>
<SENT sid="4" pm="."><plain>For some diseases, he has obtained much mature experiences </plain></SENT>
<SENT sid="5" pm="."><plain>Although some are still in the stage of exploration, ideal clinical effects has been shown primarily </plain></SENT>
</text></document>